Premium
Risk factors for in‐hospital mortality of visceral leishmaniasis patients in eastern Uganda
Author(s) -
Mueller Yolanda,
Mbulamberi Dawson B.,
Odermatt Peter,
Hoffmann Axel,
Loutan Louis,
Chappuis François
Publication year - 2009
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/j.1365-3156.2009.02305.x
Subject(s) - medicine , visceral leishmaniasis , case fatality rate , concomitant , leishmaniasis , mortality rate , retrospective cohort study , risk factor , pediatrics , epidemiology , surgery , immunology
Summary Objective To identify risk factors for in‐hospital mortality in patients treated for visceral leishmaniasis (VL) in Uganda. Methods Retrospective analysis of VL patients’ clinical data collected for project monitoring by Médecins Sans Frontières in Amudat, eastern Uganda. Results Between 2000 and 2005, of 3483 clinically suspect patients, 53% were confirmed with primary VL. Sixty‐two per cent were children <16 years of age with a male/female ratio of 2.2. The overall case‐fatality rate during pentavalent antimonial ( n = 1641) or conventional amphotericin B treatment ( n = 217) was 3.7%. There was no difference in the case‐fatality rate between treatment groups ( P > 0.20). The main risk factors for in‐hospital death identified by a multivariate analysis were age <6 years and >15 years, concomitant tuberculosis or hepatopathy, and drug‐related adverse events. The case‐fatality rate among patients >45 years of age was strikingly high (29.0%). Conclusion Subgroups of VL patients at higher risk of death during treatment with drugs currently available in Uganda were identified. Less toxic drugs should be evaluated and used in these patients.